143 related articles for article (PubMed ID: 19286195)
1. Evaluation of the effect of thyrotropin releasing hormone (TRH) on regional cerebral blood flow in spinocerebellar degeneration using 3DSRT.
Kimura N; Kumamoto T; Masuda T; Nomura Y; Hanaoka T; Hazama Y; Okazaki T; Arakawa R
J Neurol Sci; 2009 Jun; 281(1-2):93-8. PubMed ID: 19286195
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of the effects of thyrotropin releasing hormone (TRH) therapy on regional cerebral blood flow in the cerebellar variant of multiple system atrophy using 3DSRT.
Kimura N; Kumamoto T; Masuda T; Nomura Y; Hanaoka T; Hazama Y; Okazaki T
J Neuroimaging; 2011 Apr; 21(2):132-7. PubMed ID: 19674246
[TBL] [Abstract][Full Text] [Related]
3. [Efficacy of TRH-T for spinocerebellar degeneration--the relation between clinical features and effect of TRH therapy].
Waragai M; Ogawara K; Takaya Y; Hayashi M
Rinsho Shinkeigaku; 1997 Jul; 37(7):587-94. PubMed ID: 9396355
[TBL] [Abstract][Full Text] [Related]
4. Alteration of regional cerebral blood flow to thyrotropin-releasing hormone therapy in acute encephalitis and encephalopathy during childhood.
Yoshinari S; Hamano S; Tanaka M; Minamitani M
Eur J Paediatr Neurol; 2006 May; 10(3):124-8. PubMed ID: 16757195
[TBL] [Abstract][Full Text] [Related]
5. Effect of thyrotropin-releasing hormone (TRH) on cerebral blood flow in spinocerebellar degeneration and cerebrovascular disease.
Izumi Y; Fukuuchi Y; Ishihara N; Imai A; Komatsumoto S
Tokai J Exp Clin Med; 1995 Dec; 20(4-6):203-8. PubMed ID: 8956461
[TBL] [Abstract][Full Text] [Related]
6. [Alteration of CBF and CMRO2 and TRH effects on CBF in spinocerebellar degeneration. The positron emission tomography study].
Harada K; Fukuyama H; Miyoshi T; Namura Y; Kameyama M
Rinsho Shinkeigaku; 1988 May; 28(5):563-8. PubMed ID: 3145826
[No Abstract] [Full Text] [Related]
7. Evaluation of regional cerebral blood flow in cerebellar variant of multiple system atrophy using FineSRT.
Kimura N; Kumamoto T; Masuda T; Nomura Y; Hanaoka T; Hazama Y; Okazaki T
Clin Neurol Neurosurg; 2009 Dec; 111(10):829-34. PubMed ID: 19735974
[TBL] [Abstract][Full Text] [Related]
8. Three-dimensional stereotactic ROI template for measuring regional cerebral blood flow in 99mTc-ECD SPECT: comparison with the manual tracing method.
Nagasawa N; Yamakado K; Yamada T; Nakanishi S; Ito M; Suzawa N; Kitano T; Takeda K
Nucl Med Commun; 2009 Feb; 30(2):155-9. PubMed ID: 19077913
[TBL] [Abstract][Full Text] [Related]
9. Differential effects of thyrotropin releasing hormone (TRH) on motor execution and motor adaptation process in patients with spinocerebellar degeneration.
Shimizu T; Tsutsumi R; Shimizu K; Tominaga N; Nagai M; Ugawa Y; Nishiyama K; Hanajima R
J Neurol Sci; 2020 Aug; 415():116927. PubMed ID: 32474221
[TBL] [Abstract][Full Text] [Related]
10. [Chronic experimentation with TRH administered intramuscularly in spinocerebellar degeneration. Double-blind cross-over study in 30 subjects].
Filla A; De Michele G; Di Martino L; Mengano A; Iorio L; Maggio MA; Campanella G
Riv Neurol; 1989; 59(2):83-8. PubMed ID: 2505370
[TBL] [Abstract][Full Text] [Related]
11. [Clinical evaluation of 99mTc ethyl cysteinate dimer SPECT in patients with spinocerebellar degeneration; comparison with cerebral blood flow determined by PET].
Oriuchi N; Tanaka M; Igarashi H; Watanabe N; Tateno M; Inoue T; Tomiyoshi K; Hirano T; Endo K; Hirai S
Kaku Igaku; 1992 Jun; 29(6):659-65. PubMed ID: 1640650
[TBL] [Abstract][Full Text] [Related]
12. The long loop reflex in spinocerebellar degeneration and motor neuron disease--its changes with TRH therapy.
Touge T; Takeuchi H; Yamada A; Miki H; Nishioka M
Electromyogr Clin Neurophysiol; 1990; 30(3):131-40. PubMed ID: 2112456
[TBL] [Abstract][Full Text] [Related]
13. [Analysis of regional cerebral blood flow and distribution volume in Machado-Joseph disease by iodine-123I IMP single photon emission computed tomography].
Hayashi T; Nakajima T; Fukuhara N
Rinsho Shinkeigaku; 2001 Sep; 41(9):574-81. PubMed ID: 11968740
[TBL] [Abstract][Full Text] [Related]
14. Regional cerebral blood flow and developmental outcome in cryptogenic West syndrome.
Hamano S; Yoshinari S; Higurashi N; Tanaka M; Minamitani M; Eto Y
Epilepsia; 2007 Jan; 48(1):114-9. PubMed ID: 17241217
[TBL] [Abstract][Full Text] [Related]
15. [Cerebello-cerebral functional relationship in spinocerebellar degeneration using positron emission tomography].
Koshi Y; Kitamura S; Sakayori O; Komaba Y; Terashi A
Rinsho Shinkeigaku; 1995 Jul; 35(7):751-7. PubMed ID: 8777798
[TBL] [Abstract][Full Text] [Related]
16. Quantitative assessment of cerebral blood flow in genetically confirmed spinocerebellar ataxia type 6.
Honjo K; Ohshita T; Kawakami H; Naka H; Imon Y; Maruyama H; Mimori Y; Matsumoto M
Arch Neurol; 2004 Jun; 61(6):933-7. PubMed ID: 15210534
[TBL] [Abstract][Full Text] [Related]
17. Relationship between thyroid hormone levels and regional cerebral blood flow in Alzheimer disease.
Kimura N; Kumamoto T; Masuda H; Hanaoka T; Hazama Y; Okazaki T; Arakawa R
Alzheimer Dis Assoc Disord; 2011; 25(2):138-43. PubMed ID: 20975518
[TBL] [Abstract][Full Text] [Related]
18. Effects of TRH on cerebral and peripheral blood flows; role of submesencephalic brain stem centres.
Koskinen LO
Acta Physiol Scand; 1986 Oct; 128(2):277-88. PubMed ID: 3096078
[TBL] [Abstract][Full Text] [Related]
19. [Relationship between cognitive function and regional CBF in hereditary spinocerebellar degeneration--comparison between Joseph disease and OPCA of Menzel type].
Koshi Y; Kitamura S; Terashi A
Rinsho Shinkeigaku; 1995 Mar; 35(3):237-42. PubMed ID: 7614743
[TBL] [Abstract][Full Text] [Related]
20. 3DSRT evaluation of responses of Alzheimer type dementia to donepezil hydrochloride therapy.
Higashiyama S; Kawabe J; Hashimoto H; Akiyama H; Kawamura E; Torii K; Inoue K; Kiriike N; Shiomi S; Inoue Y
Osaka City Med J; 2006 Dec; 52(2):55-62. PubMed ID: 17330392
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
